According to iTeos Therapeutics's latest financial reports the company's current EPS (TTM) is -0,74ย โฌ. In 2022 the company made an earnings per share (EPS) of 2,54ย โฌ a decrease over its 2021 EPS that were of 5,68ย โฌ.